Cresco Labs Inc.
CL
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 668.71M | 683.58M | 704.41M | 722.85M | 733.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 668.71M | 683.58M | 704.41M | 722.85M | 733.45M |
| Cost of Revenue | 344.93M | 345.72M | 354.93M | 359.89M | 360.10M |
| Gross Profit | 323.78M | 337.86M | 349.48M | 362.97M | 373.35M |
| SG&A Expenses | 222.18M | 227.72M | 231.60M | 229.24M | 227.40M |
| Depreciation & Amortization | 20.67M | 20.74M | 21.50M | 21.77M | 26.29M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 587.78M | 594.18M | 608.03M | 610.90M | 613.79M |
| Operating Income | 80.94M | 89.41M | 96.38M | 111.95M | 119.66M |
| Income Before Tax | -5.22M | 16.20M | -27.48M | -10.62M | -853.00K |
| Income Tax Expenses | 45.44M | 52.59M | 46.19M | 49.87M | 55.21M |
| Earnings from Continuing Operations | -50.66 | -36.38 | -73.67 | -60.49 | -56.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.54M | -9.30M | -10.01M | -13.95M | -11.37M |
| Net Income | -52.19M | -45.68M | -83.68M | -74.44M | -67.43M |
| EBIT | 80.94M | 89.41M | 96.38M | 111.95M | 119.66M |
| EBITDA | 132.79M | 143.34M | 153.05M | 171.05M | 185.10M |
| EPS Basic | -0.15 | -0.13 | -0.24 | -0.22 | -0.20 |
| Normalized Basic EPS | 0.04 | 0.03 | -0.07 | -0.05 | -0.03 |
| EPS Diluted | -0.15 | -0.13 | -0.24 | -0.22 | -0.20 |
| Normalized Diluted EPS | 0.04 | 0.03 | -0.07 | -0.05 | -0.03 |
| Average Basic Shares Outstanding | 1.41B | 1.40B | 1.39B | 1.38B | 1.37B |
| Average Diluted Shares Outstanding | 1.41B | 1.40B | 1.39B | 1.38B | 1.37B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |